These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 13934278)

  • 1. A comparison of the biological activity of uracil mustard and Dopan.
    PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS
    Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713
    [No Abstract]   [Full Text] [Related]  

  • 2. [A CASE OF ACUTE POISONING WITH DOPAN].
    BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM
    Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983
    [No Abstract]   [Full Text] [Related]  

  • 3. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS].
    SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF
    Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614
    [No Abstract]   [Full Text] [Related]  

  • 4. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
    CHANG M
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    SAMPEY JR
    J S C Med Assoc; 1962 May; 58():175-6. PubMed ID: 14496660
    [No Abstract]   [Full Text] [Related]  

  • 6. Soviet antitumor preparations.
    Borisov VI
    Natl Cancer Inst Monogr; 1977 Mar; (45):235-44. PubMed ID: 73136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological comparisons on a new antitumor agent: dopan].
    MAZZUCCHELLI L
    Boll Chim Farm; 1962 Aug; 101():630-2. PubMed ID: 13934278
    [No Abstract]   [Full Text] [Related]  

  • 8. [CHEMOTHERAPY OF UTERINE CERVIX CARCINOMA].
    PERITI P; MAIJNELLI M
    Riv Ostet Ginecol; 1964 Jan; 19():56-60. PubMed ID: 14165768
    [No Abstract]   [Full Text] [Related]  

  • 9. Design of cancer chemotherapy: tailored sensitivity assays.
    Syrkin AB
    Antibiot Chemother (1971); 1980; 28():8-12. PubMed ID: 6774661
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.